TEVA
$16.8
Revenue | $3832Mn |
Net Profits | $-139Mn |
Net Profit Margins | -3.63% |
Teva Pharmaceutical Industries Ltd’s revenue jumped 4.67% since last year same period to $3832Mn in the Q1 2024. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated -14.02% fall in its revenue since last 3-months.
Teva Pharmaceutical Industries Ltd’s net profit jumped 32.2% since last year same period to $-139Mn in the Q1 2024. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated -132.4% fall in its net profits since last 3-months.
Teva Pharmaceutical Industries Ltd’s net profit margin jumped 35.22% since last year same period to -3.63% in the Q1 2024. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated -137.69% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.55 |
EPS Estimate Current Year | 0.55 |
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current quarter stand at 0.55 - a 7.84% jump from last quarter’s estimates.
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current year stand at 0.55.
Earning Per Share (EPS) | 0.48 |
Return on Assets (ROA) | 0.05 |
Return on Equity (ROE) | -0.1 |
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) jumped 20% since last year same period to 0.48 in the Q1 2024. This indicates that the Teva Pharmaceutical Industries Ltd has generated 20% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Teva Pharmaceutical Industries Ltd’s return on assets (ROA) stands at 0.05.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Teva Pharmaceutical Industries Ltd’s return on equity (ROE) stands at -0.1.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-05-08 | 0.51 | 0.48 | -5.88% |